CIRM’s core programs focus on critical areas that drive the development and commercialization of regenerative medicine treatments. Spanning education, research, and funding opportunities, these ...

CIRM’s Education and Training programs are a vital link to tomorrow. The California Institute for Regenerative Medicine (CIRM) offers invaluable educational and training pathways in regenerative ...

At the heart of our outreach are strong community partnerships, built on trusted relationships with local leaders who engage directly with community members and connect groundbreaking research to the ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to ...

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

CIRM is dedicated to bringing regenerative medicine treatments to patients who need them. This commitment begins with access to information. This page provides resources to learn more about ...

Many stem cell clinics, both in the U.S. and in other countries, advertise cures for a price. Understand the concerns over stem cell tourism and what CIRM is doing to bring real cures to patients who ...

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

Currently, CIRM is not accepting new applications for any existing Clinical (CLIN), Translational (TRAN), Education (EDUC), or Infrastructure (INFR) opportunities. However, CIRM will accept ...